Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 13Neoplasms 12Colorectal Neoplasms 12Pain 11Pain, Postoperative 9Prostatic Neoplasms 7Lung Neoplasms 7Agnosia 6Colonic Neoplasms 5Cancer Pain 5Neuralgia 4Keratosis, Actinic 4Head and Neck Neoplasms 4Liver Neoplasms 3Leiomyoma 3Chronic Pain 3Thyroid Neoplasms 2Stomatitis 2Stomach Neoplasms 2Recurrence 2Pilonidal Sinus 2Oropharyngeal Neoplasms 2Neoplasm Metastasis 2Myofibroma 2Mucositis 2Inflammatory Bowel Diseases 2Ileus 2Diverticulitis 2Carcinoma, Non-Small-Cell Lung 2Wounds and Injuries 1

Interventions

resiniferatoxin 3Ketamine 3Morphine 2Methadone 2Dexmedetomidine 2ziconotide 1substance P-saporin 1Standard of Care 1Sodium Chloride 1Ropivacaine 1Registries 1Pregabalin 1Passive Cutaneous Anaphylaxis 1Midazolam 1Lidocaine 1Infusion Pumps, Implantable 1Hydromorphone 1Fentanyl 1Calcium Dobesilate 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain, Intractable × Lidocaine × Clear all
NCT04085120 2019-09-11

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

All India Institute of Medical Sciences

Phase NA Unknown
60 enrolled
Head & Neck

Cancer Pain, Oropharyngeal Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡